Opioid abuse + Treatment -- United States
Label
Opioid abuse + Treatment -- United States
Name
Opioid abuse + Treatment
Sub focus
Actions
Incoming Resources
- Subject of50
- Opioid Addiction Recovery Fraud Prevention Act of 2018, report of the Committee on Commerce, Science, and Transportation on S. 2842
- Opioid treatment programs for people with Medicare
- The opioid crisis, impact on children and families : hearing of the Committee on Health, Education, Labor, and Pensions, United States Senate, One Hundred Fifteenth Congress, second session, on examining the opioid crisis, focusing on the impact on children and families, February 8, 2018
- Close to home, how opioids are impacting communities : joint hearing before the Subcommittee on Early Childhood, Elementary and Secondary Education and the Subcommittee on Higher Education and Workforce Development of the Committee on Education and the Workforce, U.S. House of Representatives, One Hundred Fifteenth Congress, first session, hearing held in Washington, DC, November 8, 2017
- Medication-assisted treatment for opioid addiction in opioid treatment programs
- Overcoming opioid addiction, the authoritative medical guide for patients, families, doctors, and therapists, Adam Bisaga, MD, with Karen Chernyaev ; forword by A. Thomas McLellan, PhD
- Behavioral intervention techniques in drug abuse treatment, editors: John Grabowski, Maxine L. Stitzer, Jack E. Henningfield
- Medication-assisted treatment for opioid addiction in opioid treatment programs, Steven L. Batki [and others]
- At-Risk Youth Medicaid Protection Act of 2018, report (to accompany H.R. 1925) (including cost estimate of the Congressional Budget Office)
- Preparing for your baby: information for pregnant people with substance use disorders
- Resources for professionals working with pregnant and parenting people affected by substance use disorders
- Expanding Findings for Federal Opioid Research and Treatment Act, report of the Committee on Commerce, Science, and Transportation on H.R. 3153
- Health Insurance for Former Foster Youth Act, report (to accompany H.R. 4998) (including cost estimate of the Congressional Budget Office)
- Advancing High Quality Treatment for Opioid Use Disorders in Medicare Act, report (to accompany H.R. 5605) (including cost estimate of the Congressional Budget Office)
- Access to Telehealth Services for Substance Use Disorders Act, report (to accompany H.R. 5603) (including cost estimate of the Congressional Budget Office)
- Opioid addiction, laws, regulations, and other factors can affect medication-assisted treatment access, report to the Majority Leader, U.S. Senate
- Post-Surgical Injections as an Opioid Alternative Act, report (to accompany H.R. 5804) (including cost estimate of the Congressional Budget Office)
- Every Prescription Conveyed Securely Act, report (to accompany H.R. 3528) (including cost estimate of the Congressional Budget Office)
- Family First Prevention Services Act (FFPSA), Emilie Stoltzfus
- Medicaid coverage of medications to reverse opioid overdose and treat alcohol and opioid use disorders
- Medications to treat opioid addiction
- Examining Opioid Treatment Infrastructure Act of 2016, report (to accompany H.R. 4982) (including cost estimate of the Congressional Budget Office)
- State Opioid Response Grant Authorization Act of 2021, report (to accompany H.R. 2379)
- Individuals in Medicaid Deserve Care that is Appropriate and Responsible in its Execution Act, report together with dissenting views (to accompany H.R. 5797) (including cost estimate of the Congressional Budget Office)
- Patients who are privately insured receive limited follow-up services after opioid-related hospitalizations, Mir M. Ali and Ryan Mutter
- The role of federal housing and community development programs to support opioid and substance use disorder treatment and recovery, hearing before the Subcommittee on Housing and Insurance of the Committee on Financial Services, U.S. House of Representatives, One Hundred Fifteenth Congress, second session, August 16, 2018
- The opioid crisis, leadership and innovation in the states : hearing of the Committee on Health, Education, Labor, and Pensions, United States Senate, One Hundred Fifteenth Congress, second session, on examining the opioid crisis, focusing on leadership and innovation in the states, March 8, 2018
- The facts about buprenorphine for treatment of opioid addiction
- Pharmacologic guidelines for treating individuals with post-traumatic stress disorder and co-occurring opioid use disorders
- Easy Medication Access and Treatment for Opioid Addiction Act, report (to accompany H.R. 2281)
- Examining advertising and marketing practices within the substance use treatment industry, hearing before the Subcommittee on Oversight and Investigations of the Committee on Energy and Commerce, House of Representatives, One Hundred Fifteenth Congress, second session, July 24, 2018
- State Opioid Response Grant Authorization Act of 2020, report (to accompany H.R. 2466)
- Use of medication-assisted treatment for opioid use disorder in criminal justice settings
- Raising Lazarus, hope, justice, and the future of America's overdose crisis, Beth Macy
- Información sobre la buprenorfina para el tratamiento de la adicción a los opiáceos
- Opioids in the homeland, DHS coordination with state and local partners to fight the epidemic : field hearing before the Subcommittee on Oversight and Management Efficiency of the Committee on Homeland Security, House of Representatives, One Hundred Fifteenth Congress, second session, June 19, 2018
- Opioids in Indian Country, beyond the crisis to healing the community : hearing before the Committee on Indian Affairs, United States Senate, One Hundred Fifteenth Congress, second session, March 14, 2018
- How HIPAA allows doctors to respond to the opioid crisis
- The facts about naltrexone for treatment of opioid addiction
- Medication-assisted treatment for opioid addiction, facts for families and friends
- The opioids epidemic, implications for America's workplaces : joint hearing before the Subcommittee on Health, Employment, Labor and Pensions and the Subcommittee on Workforce Protections of the Committee on Education and the Workforce, U.S. House of Representatives, One Hundred Fifteenth Congress, second session : hearing held in Washington, DC, February 15, 2018
- Commit to Opioid Medical Prescriber Accountability and Safety for Seniors Act, report (to accompany H.R. 5716) (including cost estimate of the Congressional Budget Office)
- Statistical issues in clinical trials for treatment of opiate dependence, editor: Ram B. Jain
- Medicare coverage of Medication Assisted Treatment (MAT) for opioid addiction, Suzanne M. Kirchhoff, Johnathan H. Duff
- An Act to Direct the Director of the National Science Foundation to Support Research on Opioid Addiction, and For Other Purposes
- Substance Use-Disorder Prevention that Promotes Opioid Recovery and Treatment for Patients and Communities Act.
- Opioid treatment programs and related federal regulations, Johnathan H. Duff
- KAP keys for clinicians, based on TIP 43, medication-assisted treatment for opioid addiction in opioid treatment programs
- Buprenorphine, an alternative treatment for opioid dependence, editor: Jack D. Blaine
Outgoing Resources
- Focus1
- Sub focus3